1-3 of 3
Ann Van de Velde, MD
Close
Sort by
Journal Articles

Prevention Of Relapse In Acute Myeloid Leukemia By Dendritic Cell Vaccination: Report on a Phase II Study With 29 Patients

Zwi N. Berneman, MD, PhD, FRCP, Ann Van de Velde, MD, Sébastien Anguille, MD, Yannick Willemen, MD, Wilfried A. Schroyens, MD, PhD, Alain P. Gadisseur, MD, PhD, Inge Vrelust, MD, Griet Nijs, MT, Barbara Stein, MSc, Nathalie Cools, PhD, Ronald Malfait, MD, Marie-Berthe Maes, PharmD, PhD, Katrien Vermeulen, PhD, Viggo F. Van Tendeloo, PhD, Evelien L. Smits, PhD
Journal: Blood
Blood (2013) 122 (21): 236.
https://doi.org/10.1182/blood.V122.21.236.236
Published: 2013
Journal Articles

The Survival of Multiple Myeloma Patients: A Single Institution Study.

Zwi N. Berneman, MD, PhD, An-Sofie Verstraete, MD, Alain Gadisseur, MD, Ann Van de Velde, MD, Wilfried A. Schroyens, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 5223.
https://doi.org/10.1182/blood.V104.11.5223.5223
Published: 2004
Journal Articles

Immunotargetting of the Wilms’ Tumor WT1 Antigen for Dendritic Cell and B-Cell-Based Vaccination of Leukemia.

Zwi N. Berneman, MD, PhD, Ann Van Driessche, BSc, Peter Ponsaerts, PhD, Liquan Gao, MD, Hans J. Stauss, MD, PhD, Wilfried A. Schroyens, MD, PhD, Ann Van de Velde, MD, Alain Gadisseur, MD, Marc Lenjou, MT, Griet Nijs, MT, Dirk R. Van Bockstaele, PhD, Viggo F. Van Tendeloo, PhD
Journal: Blood
Blood (2004) 104 (11): 2541.
https://doi.org/10.1182/blood.V104.11.2541.2541
Published: 2004